Autonomix Medical Inc. Co... (AMIX)
Autonomix Medical Common Stock Statistics
Share Statistics
Autonomix Medical Common Stock has 1.77M shares outstanding. The number of shares has increased by -90.6% in one year.
| Shares Outstanding | 1.77M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -92.33% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.24M |
| Failed to Deliver (FTD) Shares | 68.26K |
| FTD / Avg. Volume | 7.68% |
Short Selling Information
The latest short interest is 109.44K, so 6.19% of the outstanding shares have been sold short.
| Short Interest | 109.44K |
| Short % of Shares Out | 6.19% |
| Short % of Float | 9.18% |
| Short Ratio (days to cover) | 0.63 |
Valuation Ratios
The PE ratio is -2.84 and the forward PE ratio is -1.43.
| PE Ratio | -2.84 |
| Forward PE | -1.43 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 5.75 |
| P/FCF Ratio | -6.58 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Autonomix Medical Inc. Common Stock.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.09, with a Debt / Equity ratio of 0.13.
| Current Ratio | 12.09 |
| Quick Ratio | 12.09 |
| Debt / Equity | 0.13 |
| Total Debt / Capitalization | 11.61 |
| Cash Flow / Debt | -6.63 |
| Interest Coverage | -94.61 |
Financial Efficiency
Return on equity (ROE) is -2.02% and return on capital (ROIC) is -86.6%.
| Return on Equity (ROE) | -2.02% |
| Return on Assets (ROA) | -1.64% |
| Return on Capital (ROIC) | -86.6% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -3.09M |
| Employee Count | 5 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Autonomix Medical Common Stock's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 5.6 |
| 200-Day Moving Average | 21.95 |
| Relative Strength Index (RSI) | 39.82 |
| Average Volume (20 Days) | 889.26K |
Income Statement
| Revenue | n/a |
| Gross Profit | -81.00K |
| Operating Income | -7.47M |
| Net Income | -15.43M |
| EBITDA | -15.27M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -21.1 |
Balance Sheet
The company has 8.61M in cash and 1.00M in debt, giving a net cash position of 7.61M.
| Cash & Cash Equivalents | 8.61M |
| Total Debt | 1.00M |
| Net Cash | 7.61M |
| Retained Earnings | -38.97M |
| Total Assets | 5.37M |
| Working Capital | 4.10M |
Cash Flow
In the last 12 months, operating cash flow was -6.65M and capital expenditures -19.00K, giving a free cash flow of -6.67M.
| Operating Cash Flow | -6.65M |
| Capital Expenditures | -19.00K |
| Free Cash Flow | -6.67M |
| FCF Per Share | -9.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AMIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -701% |
| FCF Yield | -125.3% |
Analyst Forecast
Currently there are no analyst rating for AMIX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -17.77 |
| Piotroski F-Score | 2 |